Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Axsome Therapeutics, Inc. related to misrepresentation of the company's practices and prospects [1] Group 1: Allegations of Misrepresentation - Insiders at Axsome allegedly caused the company to misrepresent or fail to disclose deficiencies in its chemistry, manufacturing, and control (CMC) practices concerning AXS-07 [2] - As a result of these deficiencies, Axsome was unlikely to submit the AXS-07 New Drug Application (NDA) on the initially represented timeline [2] - The unresolved CMC issues were present during the FDA's review of the AXS-07 NDA, leading to a low likelihood of FDA approval [2] - Consequently, Axsome overstated AXS-07's regulatory and commercial prospects, making the company's public statements materially false and misleading [2]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of New Fortress Energy Inc. (NASDAQ: NFE) towards shareholders [1] Group 1: Allegations and Legal Actions - A federal securities lawsuit claims that insiders at New Fortress misrepresented the company's projected revenue outlook and growth while minimizing risks related to the Fast LNG projects [2] - The Fast LNG projects failed to meet publicly stated progress, particularly the expectation that FLNG 1 would be operational by March 2024 [2] Group 2: Shareholder Participation - Shareholders who purchased NFE shares prior to February 29, 2024, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3] - Kuehn Law covers all case costs and does not charge investor clients, emphasizing the importance of shareholder involvement in maintaining market integrity [4]